According to the Zhitong Finance App, Kaisa Health (00876) announced its 2026 interim results, with earnings of about HK$285 million, a year-on-year decrease of about 15.85%; losses attributable to the company's equity holders were HK$60.68 million, an increase of about 6.77 times over the previous year; and a loss of 1.24 HK cents per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.